Combine the best of both worlds

Similar documents
NIRxcell CoCr Coronary Stent System

Coroflex ISAR. Sirolimus Eluting Polymer-Free Coronary Stent System. Vascular Systems

NC EMERGE TM PTCA Dilatation Catheter

Vascular Intervention // Coronary Drug-Eluting Stent System. Orsiro. Clinically proven. Highly deliverable. Ultrathin 60 μm struts

Yukon Chrome PC. Translumina trust is what counts. Sirolimus Eluting CoCr Coronary Stent System. 5-Years Randomized Clinical Follow-Up

XIENCE Sierra INTRODUCING

Yukon Choice PC Translumina trust is what counts

The Art of. Flow Restoration. Ikazuchi Zero. Semi-Compliant PTCA Balloon OVERVIEW CROSSABILITY LOW PROFILE CASE STUDY CODES

EXPERIENCE MAGIC IN ITS TOUCH

EluNIR. Ridaforolimus Eluting Coronary Stent System. Advancing Deliverability for the Road Ahead

Chronic Total Occlusion (CTO) Technologies

NON-COMPLIANT PTCA RAPID EXCHANGE DILATATION CATHETER

Innovation by design. Technology that sets a new standard

Chronic Total Occlusion (CTO) Technologies. Re-open vital channels

Finally, the Control You Need to Deliver Accurate Treatment

Non stent based intracoronary drug delivery

Advanced Innovation for Exceptional Performance

INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY. SeQuent Please OTW PERIPHERAL DRUG COATED BALLOON CATHETER

Balloon Expandable Covered Stents. Suddenly a Crowded Space

RECOMMENDED INSTRUCTIONS FOR USE

COMPANY INTRODUCTION: PROFILE & PRODUCTS

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18

Penumbra INTRACRANIAL ACCESS REDEFINED

New Devices Pedro Pinto Cardoso

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

EXPERIENCE MAGIC IN ITS TOUCH MAGIC TOUCH

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

COMPLEX CASES: LEFT MAIN

Drug delivery to the vessel wall: Coated balloons and the role of the excipient

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES

Peripheral Intravascular Lithotripsy (IVL) Catheter Instructions for Use (IFU)

Zenith Alpha T HORACIC ENDOVASCULAR GRAFT

Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR

INTRODUCING. Cordis POWERFLEX Pro PTA Dilatation Catheter

DURABLE. CONSISTENT. SAFE. IN.PACT Admiral Drug-Coated Balloon

Zenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up

Anatomy and Classification of Aortic Dissection

Ruby Coil. Large Volume Detachable Coils

Tailored bifurcation therapy

Lutonix AV Clinical Trial

PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!!

We Catch. What Others Miss

A Paclitaxel-Eluting Balloon for Bifurcation Lesions : Early Clinical Observations

thoracic stent graft system Smallest delivery profile as from 20 F

1 Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. N Engl J Med 352;13, March 31, 2005

ABDOMINAL XT ABDOMINAL STENT GRAFT SYSTEM

PTCA Dilatation Catheter. Instructions for Use

Proven Performance Through Innovative Design *

BioCath for your temporary vascular access

MICRO-TECH Europe. MICRO-TECH Colon and rectum stents. Colon and rectum stents

CP STENT. Large Diameter, Balloon Expandable Stent

-vita THORACIC 3G. Stent Graft System SOLUTIONS FOR VASCULAR DISEASE

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.

Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM

The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use

ER REBOA Catheter. Instructions for Use

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER

NAVIGATE DISTAL AND TORTUOUS ANATOMY

Guide Wires design and selection Abbott Vascular. All rights reserved.

5-YEAR SUPERIOR RESULTS. Compared to PTA and Zilver BMS 1. NOW WITH 140 mm LENGTH STENTS

Vascular V12. Covered Stent. The New Standard of Care

Stent thrombosis: How to manage it Dr Philip MacCarthy BSc PhD FRCP Consultant Cardiologist King s College Hospital, London, UK.

1/22/2017. Ultimaster Clinical evidence. Hazem Khamis,MD,FACC October 6 University Egypt

The choice of a unique formulation, coupled with a prolonged polymerfree elution, maximizes DES efficacy. R. Byrne Deutsches Herzzentrum München

PTCA Dilatation Catheter. Instructions for Use

PERIPHERAL US PRODUCT

Extracorporeal Circuit Cannulae { VENOUS}

Maximise Clinical Safety*. Cordis ExoSeal. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

Technical Characteristics of coronary prostheses(stents)

Indications for use. Contraindications within the United States

E S C C R I A L T E A R. One great catheter + maximum barrier insertion. c k. p a. h e. a t. a l. r i t e. A r

The tailored solution for your bifurcation therapy

Quick Reference Guide

Rhinology Products. Rhinology Products. Superior solutions for superior patient care.

Cardioplegia Circuit Products { ANTEGRADE}

Polymer-Free Stent CX - ISAR

Rationale and algorithm for below-the-knee acute gain optimization

Talent Abdominal Stent Graft

Drug eluting balloons in CAD

Investigation of metallic surface area of coronary stents

Eulogio Garcia MD H. U. Gregorio Marañon Madrid

PERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System

C ARDIAC INTERVENTION

Access More Patients. Customize Each Seal.

Colonic Metal Stents MAKING A DIFFERENCE TO HEALTH

Solitaire FR Revascularization Device

Welcome to the 8 th European Bifurcation Club October Barcelona

DK Crush,Culotte,SKS,T or TAP. Subhash Chandra, MD,DM,FACC Chairman,Cardiac Sciences BLK Super Speciality Hospital, Pusa Road, New Delhi

Optimized for Performance and Ease of Use. Designed with Titanium Oxide Surface. References

Catch-up Phenomenon: Insights from Pathology

Next Generation of DCB: Efficacy and tolerance of drug-coated hyper-compliant balloons (DCHCB) in peripheral arteries of swine

REBEL. Platinum Chromium Coronary Stent System. Patient Information Guide

Appropriate Device Selection for Endovascular Procedures

THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT

Gastric / EUS Metal Stents

LINEAR 7.5Fr. IAB Catheter

Measurement of Mechanical Properties of Coronary Stents according to the European Standard pren

FROM THE EVERYDAY TO THE EXTRAORDINARY

Ostial Stents and Distal Embolic Protection During Renal Stenting

Transcription:

S c i e n c e B a s e d E v o l u t i o n s l e a d t o R e v o l u t i o n a r y S o l u t i o n s

PIONEER CoCr STENT ON DEB Combine the best of both worlds A next step in cardiovascular treatment should consist of increasing treatment effectiveness while reducing risk and medication requirements. This has led to the obvious solution of a CoCr stent on an drug eluting balloon. Picking up where DES and BMS left of, Pioneer ensures the best of both worlds in one, setting a new standard in treating coronary disease. Entering the next phase in coronary intervention Reduced late lumen loss normally associated with drug eluting stents is now combined with the ease of use and proven safety of bare metal stents represented in: Fast and complete re-endothelialization No increased risk of late thrombus No long term dual anti-platelet therapy

PIONEER CoCr STENT ON DEB COMBINE THE BEST OF BOTH Increased treatment effectiveness, reduced risk and medication requirements - Hydrophilic coating delivers Paclitaxel without any negative side effects or inflammation - Vessel healing not interrupted and stable within days after procedure - Re-endothelialization starts within days after procedure - No increased late thrombus risk - No pre-delitation required, direct stenting does not influence drug delivery - Anti platelet therapy can be reduced to BMS standards Safe and reproducible drug delivery - Drug incorporated in hydrophillic coating, no accidental release or airborne drug particles - Drug component encapsulated using unique Wing-Seal Technology - Minimized drug content in contact with operator - Minimized drug loss in bloodstream prior to inflation securing reliable drug dose delivery - Hydrophilic coating delivers Paclitaxel to the vessel wall instantaneoulsy upon contact - Homogeneous distribution of Paclitaxel to vessel tissue in contact - Load secured to achieve the therapeutic window within 30 seconds inflation time

WORLDS: Co CR STENT ON DEB Proven stent technology ensures easy deliverability and use - Pioneer delivery system based on the proven CoCr stent of the Track family - Stent technology optimized to reach and cross the most difficult lesions - Low profile atraumatic tip: lesion entry profile 0.016 (0.40mm) - Wig shaped transition from tip to balloon for smoother crossing - Hydrophilic coated balloon cushions embedding stent struts reducing entry friction and profile - Superior push, track, re-wrap and re-fold - Unsurpassed stent retention guarantees safety and delivery succes - Precise balloon to stent length fitting ensures no balloon overhang - 5F guiding catheter compatible The recognized and appreciated proven characteristics of the Track CoCr stent are all maintained in the Pioneer. The stent s extreme flexibility provised an unsurpassed ability to reach through challenging anatomy and to conform to the vessel without straightening the artery. Image: Stent 10-28 mm 2.50-4.00 Diameter

CoCr Coronary Stent COMPLIANCE CHART Pressure ø 2.50 ø 2.75 ø 3.00 ø 3.25 ø 3.50 ø 4.00 (bar)* (mm) (mm) (mm) (mm) (mm) (mm) 5 2.17 2.45 2.66 2.88 3.10 3.60 6 2.23 2.49 2.71 2.94 3.17 3.67 7 2.28 2.54 2.77 3.01 3.24 3.74 8 2.34 2.59 2.82 3.07 3.31 3.81 9 2.40 2.65 2.88 3.13 3.38 3.88 10 2.45 2.70 2.94 3.19 3.45 3.94 11 NP 2.50 2.75 3.00 3.25 3.50 4.00 12 2.53 2.81 3.05 3.32 3.58 4.06 13 2.56 2.86 3.10 3.37 3.64 4.12 14 2.61 2.91 3.16 3.43 3.70 4.18 15 2.65 2.96 3.20 3.48 3.75 4.23 16 2.69 3.01 3.25 3.53 3.80 4.28 17 2.72 3.06 3.29 3.57 3.85 4.33 18 RBP 2.76 3.11 3.34 3.62 3.90 4.38 19 2.80 3.15 3.38 3.67 3.95 4.44 20 2.83 3.19 3.42 3.71 4.00 4.49 21 2.87 3.24 3.46 3.76 4.06 4.55 22 2.91 3.29 3.51 3.82 4.12 4.62 NP: Nominal Pressure RBP: Rated Burst Pressure. Do not exceed * 1bar = 100 kpa

TECHNICAL DATA Stent Stent material: F562 Cobalt Chromium Strut thickness: 0.0035 (0.088 mm) Strut width: 0.0034 (0.086 mm) Maximum expansion diameter: 4.7 mm Metal to artery ratio: ~ 14% Average recoil: Low <4% Average foreshortening: Minimal <2.5% Crush resistance: High; 0.15N/ mm Radiopacity: High Stent flexibility: Very high Delivery system Nominal Pressure: 11 bar Rated Burst Pressure: 18 bar (except Ø 4.0 = 15 bar) Balloon material: Semi-compliant polyamide Balloon folds: 3-folds; Wing-Seal Technology Drug Paclitaxel (3.0 µg/mm², Drug loaded balloon surface) Balloon overhang: Minimal Average deflation time: 3 seconds (Ø 3.0) Guiding catheter compatibility: 5F (min ID 0.056 ) Guide wire compatibility: Max. 0.014 (0.36 mm) Catheter type: Rapid Exchange Proximal shaft: 1.9F (0.64 mm) Distal shaft: 2.7F (0.90 mm) Tip: Short, thin and soft 3 mm tip Lesion entry profile: 0.016 (0.40 mm) Average crossing profile: 1.0 1.1 mm (0.039-0.043 ) Catheter coating: Hydrophilic coating Usable catheter length: 154 cm For additional details please refer to our website www.bluemedical.com.

ORDER NUMBERS Diameter (mm) L 2.50 2.75 3.00 3.25 3.50 4.00 10 PIO2510 PIO2710 PIO3010 PIO3210 PIO3510 PIO4010 14 PIO2514 PIO2714 PIO3014 PIO3214 PIO3514 PIO4014 Length (mm) 18 PIO2518 PIO2718 PIO3018 PIO3218 PIO3518 PIO4018 22 PIO2522 PIO2722 PIO3022 PIO3222 PIO3522 PIO4022 28 PIO2528 PIO2728 PIO3028 PIO3228 PIO3528 PIO4028 Order number description: PIO DDLL (D=Diameter, L=Length) L Stent and balloon working area is located between the radiopaque markers. 154 cm BLUE MEDICAL DEVICES B.V., PANOVENWEG 7, 5708 HR HELMOND, THE NETHERLANDS PHONE: +31 (0)492 58 89 00, FAX: +31 (0)492 58 89 09, E-MAIL: CS@BLUEMEDICAL.COM, WWW.BLUEMEDICAL.COM Indications, contraindications, warnings and instruction for use can be found in the product labeling. CAUTION: restricted to sale by or on the order of a physician PIO9.0001.03 02/2015